Use of Combined Liothyronine and Thyroxine Therapy for Consumptive Hypothyroidism Associated with Hepatic Haemangiomas in Infancy

被引：9
|
作者：
Peters, Catherine [1 ,2 ]
Langham, Shirley [1 ,2 ]
Mullis, Primus E. [3 ]
Dattani, Mehul T. [1 ,2 ]
机构：
[1] Great Ormond St Hosp Sick Children, Dept Paediat Endocrinol, London, England
[2] Inst Child Hlth, London, England
[3] Univ Bern, Inselspital, Univ Childrens Hosp, Dept Paediat Endocrinol Diabetol & Metab, CH-3010 Bern, Switzerland
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2010年 / 74卷 / 02期
关键词：
Hepatic haemangioma; Hypothyroidism; Type; 3; deiodinase; Reverse T(3); DEIODINASE;
D O I：
10.1159/000281884
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hepatic haemiangiomas in infancy are rare. An association with hypothyroidism has been previously reported and is believed to be secondary to the conversion of thyroxine (fT(4)) to biologically inactive reverse triiodothyronine (rT(3)) by type 3 iodothyronine deiodinase (D(3)). We report a case that responded well to the combined use of liothyronine and thyroxine therapy. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码：149 / 152
页数：4
相关论文
共 42 条
  • [31] Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma
    Botella-Carretero, JI
    Gómez-Bueno, M
    Barrios, V
    Caballero, C
    García-Robles, R
    Sancho, J
    Escobar-Morreale, HF
    ENDOCRINE-RELATED CANCER, 2004, 11 (02) : 345 - 356
  • [32] Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′-triiodothyronine therapy
    Appelhof, BC
    Peeters, RP
    Wiersinga, WM
    Visser, TJ
    Wekking, EM
    Huyser, J
    Schene, AH
    Tijssen, JGP
    Hoogendijk, WJG
    Fliers, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11): : 6296 - 6299
  • [33] Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine
    Bousser, MG
    Conard, J
    Kittner, S
    de Lignières, B
    MacGregor, EA
    Massiou, H
    Silberstein, SD
    Tzourio, C
    CEPHALALGIA, 2000, 20 (03) : 155 - 156
  • [34] Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction
    Labos, Christopher
    Dasgupta, Kaberi
    Nedjar, Hacene
    Turecki, Gustavo
    Rahme, Elham
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (16) : 1835 - 1843
  • [35] Adjunctive use of low dose intralipid associated with hemodynamic improvement in combined amlodipine and labetalol overdose refractory to standard therapy
    Troendle, Michelle M.
    Cumpston, Kirk L.
    Powell, Amber O.
    Wills, Brandon K.
    Stromberg, Paul E.
    Rose, S. R.
    CLINICAL TOXICOLOGY, 2013, 51 (07) : 650 - 651
  • [36] Adjunctive Use of Low-Dose Intralipid Associated With Hemodynamic Improvement in Combined Amlodipine and Labetalol Overdose Refractory to Standard Therapy
    Cumpston, Kirk L.
    Gopaul, Ravindra
    Wills, Brandon
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (04) : E485 - E485
  • [37] A Meta-Analysis into the Effects of Leptin Replacement Therapy on Metabolic and Hepatic Endpoints of Patients with Lipodystrophy Syndromes Not Associated with the Use of HIV Protease Inhibitors
    Paz-Filho, Gilberto J.
    Neeman, Teresa
    Mastronardi, Claudio Alberto
    Rodriguez, Alexander J.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [38] Risk of erythrocytosis associated with combined use of sodium-glucose cotransporter-2 inhibitors and testosterone replacement therapy in persons with type 2 diabetes
    Schumacher, K.
    Gemoets, D. E.
    Gosmanov, A. R.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S349 - S349
  • [39] Emergence of HBV core mutations is associated to a weaker HBV core specific T-cell response and failure to clear hepatitis B virus during combined lamivudine and interferon alpha therapy in infancy-acquired infection
    Kraslova-Carey, I
    Cavers, M
    D'Antiga, L
    Ma, Y
    Bansal, S
    Mieli-Vergani, G
    Vergani, D
    HEPATOLOGY, 2005, 42 (04) : 223A - 224A
  • [40] Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma
    Hwang, Shelley Ji Eun
    Park, John Jae Won
    Wakade, Deepal
    Chou, Shaun
    Byth, Karen
    Fernandez-Penas, Pablo
    MELANOMA RESEARCH, 2019, 29 (02) : 172 - 177
12345